Bank of Montreal
KNSA icon

Bank of Montreal’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bank of Montreal’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-985
Closed -$18K – 4322
2021
Q1 		$18K Sell
985
-3,128
-76% -$64K ﹤0.01% 4100
2020
Q4 		$81K Buy
4,113
+2,875
+232% +$50.5K ﹤0.01% 3692
2020
Q3 		$23K Sell
1,238
-282
-19% -$5.29K ﹤0.01% 3776
2020
Q2 		$35K Buy
+1,520
New +$31.8K ﹤0.01% 3595
2020
Q1 		– Sell
-1,772
Closed -$20K – 4394
2019
Q4 		$20K Buy
1,772
+549
+45% +$4.77K ﹤0.01% 4317
2019
Q3 		$10K Buy
1,223
+49
+4% +$541 ﹤0.01% 4411
2019
Q2 		$16K Buy
+1,174
New +$18.2K ﹤0.01% 4301
2019
Q1 		– Sell
-92
Closed -$3K – 4528
2018
Q4 		$3K Buy
92
+47
+104% +$981 ﹤0.01% 4257
2018
Q3 		$1K Sell
45
-8,955
-100% -$174K ﹤0.01% 4548
2018
Q2 		$156K Buy
+9,000
New +$163K ﹤0.01% 2888

Other funds holding KNSA

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Bank of Montreal's KNSA Position: Q2 2021 in Review

Bank of Montreal sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2021, closing a stake of 985 shares — an estimated $18K sold.

Bank of Montreal first reported a position in KNSA in Q2 2018 and held it in 10 quarters. The position peaked at $156K in Q2 2018. 102 funds tracked by Wall St. Rank hold KNSA as of Q2 2021.

  • Bank of Montreal reported no remaining Kiniksa Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 985 Kiniksa Pharmaceuticals shares in Q2 2021, an estimated $18K.
  • Bank of Montreal first reported a position in Kiniksa Pharmaceuticals in Q2 2018 and held it in 10 quarters.
  • Bank of Montreal's Kiniksa Pharmaceuticals position peaked at $156K in Q2 2018.
  • 102 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.